Abstract
n-Butyl carbamic acid methyl ester has been shown to be a potent inhibitor of canine liver and kidney lipases both in vitro and in vivo. The nature of this inhibition has been investigated and mechanisms consistent with the data are proposed. When this inhibitor is intravenously administered to dogs in suitable doses, a marked degree of inhibition of liver and kidney lipases has been demonstrated both by direct assay and by the greatly diminished rate of elimination of procaine from the plasma of dogs treated with this compound. A remarkable species specificity has been demonstrated, since butyl carbamic acid methyl ester does not inhibit liver and kidney lipases obtained from five other species.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.